<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<html>
<head>
<title>extropians: Re: myo-inositol best at inhibiting cancer progress</title>
<meta name="Author" content="CYMM (cymm@trinidad.net)">
<meta name="Subject" content="Re: myo-inositol best at inhibiting cancer progression">
</head>
<body bgcolor="#FFFFFF" text="#000000">
<h1>Re: myo-inositol best at inhibiting cancer progression</h1>
<!-- received="Tue Oct  3 17:56:20 2000" -->
<!-- isoreceived="20001003235620" -->
<!-- sent="Tue, 3 Oct 2000 19:44:08 -0400" -->
<!-- isosent="20001003234408" -->
<!-- name="CYMM" -->
<!-- email="cymm@trinidad.net" -->
<!-- subject="Re: myo-inositol best at inhibiting cancer progression" -->
<!-- id="027f01c02d94$ee26bde0$4e3bd1d0@mismanag" -->
<!-- inreplyto="myo-inositol best at inhibiting cancer progression" -->
<strong>From:</strong> CYMM (<a href="mailto:cymm@trinidad.net?Subject=Re:%20myo-inositol%20best%20at%20inhibiting%20cancer%20progression&In-Reply-To=&lt;027f01c02d94$ee26bde0$4e3bd1d0@mismanag&gt;"><em>cymm@trinidad.net</em></a>)<br>
<strong>Date:</strong> Tue Oct 03 2000 - 17:44:08 MDT
<p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="0243.html">Jeff Davis: "Re: Capitalists and concentration camps"</a>
<li><strong>Previous message:</strong> <a href="0241.html">Gina Miller: "Re: &quot;the species' immune system&quot;"</a>
<li><strong>Maybe in reply to:</strong> <a href="0225.html">Doug Skrecky: "myo-inositol best at inhibiting cancer progression"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#242">[ date ]</a>
<a href="index.html#242">[ thread ]</a>
<a href="subject.html#242">[ subject ]</a>
<a href="author.html#242">[ author ]</a>
</ul>
<hr noshade><p>
<!-- body="start" -->
<p>
Good post Doug,
<br>
<p>Do you have references for curcumin and any sort of inhibition of
<br>
neoplasia???
<br>
<p>cymm
<br>
<p>-----Original Message-----
<br>
From: Doug Skrecky &lt;<a href="mailto:oberon@vcn.bc.ca?Subject=Re:%20myo-inositol%20best%20at%20inhibiting%20cancer%20progression&In-Reply-To=&lt;027f01c02d94$ee26bde0$4e3bd1d0@mismanag&gt;">oberon@vcn.bc.ca</a>&gt;
<br>
To: <a href="mailto:extropians-digest@extropy.com?Subject=Re:%20myo-inositol%20best%20at%20inhibiting%20cancer%20progression&In-Reply-To=&lt;027f01c02d94$ee26bde0$4e3bd1d0@mismanag&gt;">extropians-digest@extropy.com</a> &lt;<a href="mailto:extropians-digest@extropy.com?Subject=Re:%20myo-inositol%20best%20at%20inhibiting%20cancer%20progression&In-Reply-To=&lt;027f01c02d94$ee26bde0$4e3bd1d0@mismanag&gt;">extropians-digest@extropy.com</a>&gt;
<br>
Date: Tuesday, October 03, 2000 5:27 PM
<br>
Subject: myo-inositol best at inhibiting cancer progression
<br>
<p><p><em>&gt;Title
</em><br>
<em>&gt;  Evaluation of butylated
</em><br>
<em>&gt;  hydroxyanisole, myo-inositol, curcumin, esculetin,
</em><br>
<em>&gt;  resveratrol and lycopene as inhibitors of benzo[a]pyrene plus
</em><br>
<em>&gt;  4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis
</em><br>
in
<br>
<em>&gt;  A/J mice.
</em><br>
<em>&gt;Source
</em><br>
<em>&gt;  Cancer Letters.  137(2):123-30, 1999 Apr 1.
</em><br>
<em>&gt;Abstract
</em><br>
<em>&gt;  The potential activities of butylated
</em><br>
<em>&gt;  hydroxyanisole (BHA), myo-inositol, curcumin, esculetin,
</em><br>
<em>&gt;  resveratrol and lycopene-enriched tomato oleoresin (LTO) as
</em><br>
chemopreventive
<br>
<em>&gt;  agents against lung tumor induction in A/J mice by the tobacco smoke
</em><br>
<em>&gt;  carcinogens benzo[a]pyrene (BaP) and
</em><br>
<em>&gt;  4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were evaluated.
</em><br>
Groups
<br>
<em>&gt;  of 20 A/J mice were treated weekly by gavage with a mixture of BaP and
</em><br>
NNK (3
<br>
<em>&gt;  micromol each) for 8 weeks, then sacrificed 26 weeks after the first
</em><br>
<em>&gt;  carcinogen treatment. Mice treated with BHA (20 or 40 micromol) by gavage
</em><br>
2 h
<br>
<em>&gt;  before each dose of BaP and NNK had significantly reduced lung tumor
</em><br>
<em>&gt;  multiplicity. Treatment with BHA (20 or 40 micromol) by gavage weekly or
</em><br>
with
<br>
<em>&gt;  dietary BHA (2000 ppm), curcumin (2000 ppm) or resveratrol (500 ppm) from
</em><br>
1
<br>
<em>&gt;  week after carcinogen treatment until termination had no effect on lung
</em><br>
tumor
<br>
<em>&gt;  multiplicity. Treatment with dietary myo-inositol (30,000 ppm) or
</em><br>
esculetin
<br>
<em>&gt;  (2000 ppm) from 1 week after carcinogen treatment until termination
</em><br>
<em>&gt;  significantly reduced lung tumor multiplicity, with the effect of
</em><br>
<em>&gt;  myo-inositol being significantly greater than that of esculetin.
</em><br>
Treatment
<br>
<em>&gt;  with dietary LTO (167, 1667 or 8333 ppm) from 1 week before carcinogen
</em><br>
<em>&gt;  treatment until termination had no effect on lung tumor multiplicity. The
</em><br>
<em>&gt;  results of this study demonstrate that BHA is an effective inhibitor of
</em><br>
BaP
<br>
<em>&gt;  plus NNK-induced lung tumorigenesis in A/J mice when administered during
</em><br>
the
<br>
<em>&gt;  period of carcinogen treatment and that, among the compounds tested,
</em><br>
<em>&gt;  myo-inositol is most effective after carcinogen treatment.
</em><br>
<em>&gt;
</em><br>
<p><!-- body="end" -->
<hr noshade>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="0243.html">Jeff Davis: "Re: Capitalists and concentration camps"</a>
<li><strong>Previous message:</strong> <a href="0241.html">Gina Miller: "Re: &quot;the species' immune system&quot;"</a>
<li><strong>Maybe in reply to:</strong> <a href="0225.html">Doug Skrecky: "myo-inositol best at inhibiting cancer progression"</a>
<!-- nextthread="start" -->
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#242">[ date ]</a>
<a href="index.html#242">[ thread ]</a>
<a href="subject.html#242">[ subject ]</a>
<a href="author.html#242">[ author ]</a>
</ul>
<!-- trailer="footer" -->
<hr noshade>
<p>
<small>
<em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2b30</a> 
: <em>Mon May 28 2001 - 09:50:15 MDT</em>
</em>
</small>
</body>
</html>
